Successful psychopharmacotherapy of anxiety and depressive disorders improve functional limitations in patients with rheumatoid arthritis

TERAPEVTICHESKII ARKHIV(2022)

引用 0|浏览2
暂无评分
摘要
Aim. To compare changes in functional limitations in patients with rheumatoid arthritis (RA) and comorbid anxiety and depressive disorders (ADD) treated with conventional synthetic disease-modifying antirheumatic drugs (csDMARDs) alone or in combination with biologic DMARDs (bDMARDs) and/or psychopharmacotherapy (PPT), and to determine predictors of HAQ treatment response. Materials and methods. 128 RA-patients were enrolled, 86% were women with a mean age of 47.4 +/- 11.3 (M +/- SD) years and a median of RA duration - 96 [48; 228] months. Disease activity was assessed using DAS28, functional limitations - using Health Assessment Questionnaire (HAQ). The Minimal Clinical Important Difference in HAQ was considered to be 0.22. ADD were diagnosed by a licensed psychiatrist in 123 (96.1%) of RA-pts in accordance with ICD-10 in semi-structured interview. Severity of depression and anxiety was evaluated with MontgomeryAsberg Depression Rating Scale and Hamilton Anxiety Rating Scale. RA-pts with ADD were divided into the following treatment groups: 1 -.sDMARDs (n=39), 2 -.sDMARDs + PPT (sertraline or mianserine; n=43), 3 -.sDMARDs + bDMARDs (n=32), 4 -.sDMARDs + bDMARDs + PPT (sertraline or mianserine; n=9); 83 (67.5%) patients were assessed at 5-years follow-up. Multivariable logistic regression was performed to determine predictors of HAQ treatment response. Results. Only remission of anxiety and depressive symptoms at 5-yrs endpoint (OR 6.6, 95% CI 1.78-24.43, p=0.005), higher baseline HAQ (OR 2.61, 95% CI 1.12-6.11, p=0.027) and lower baseline BMI (OR 0.9, 95% CI 0.85-0.96, p=0.001) were independently associated with HAQ treatment response at 5-years follow-up. Conclusion. While ADD do affect functional limitations in patients with RA, PPT tends to attenuate the negative impact of ADD on RA outcomes, and RA patients with functional limitations should therefore be screened for depression and long-term PPT should be recommended.
更多
查看译文
关键词
rheumatoid arthritis, anxiety, depression, antidepressants, HAQ, predictors, functional limitations
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要